Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ekaterina V. Skazyvaeva"'
Publikováno v:
Терапевтический архив, Vol 95, Iss 12, Pp 1064-1074 (2023)
The global burden of inflammatory bowel disease (IBD) is currently significant and continues to grow due to the increasing prevalence of ulcerative colitis (UC) and Crohn's disease (CD), the increasing costs of diagnosis and treatment, and the high l
Externí odkaz:
https://doaj.org/article/fef5ef4d94874114b9d64c73ac23c9cc
Autor:
Igor G. Bakulin, Maria I. Skalinskaya, Igor V. Maev, Ekaterina V. Skazyvaeva, Mariia S. Zhuravleva, Larisa B. Gaikovaya, Natalia V. Bakulina, Aleksei I. Ermakov, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev
Publikováno v:
Терапевтический архив, Vol 93, Iss 8, Pp 841-852 (2021)
Treatment of inflammatory bowel diseases IBD (Crohns disease, ulcerative colitis) is aimed at achieving clinical, endoscopic and histological remission, minimizing surgical complications, and ensuring a normal quality of life. However, the use of med
Externí odkaz:
https://doaj.org/article/b1259293af26444085a9d53cbce6157d
Publikováno v:
Терапевтический архив, Vol 93, Iss 8, Pp 963-968 (2021)
Liver cirrhosis (LC) takes the main place in the structure of the pathology of the digestive system in terms of the frequency of mortality, as well as in the development of fatal and poorly controlled complications, which requires the search for effe
Externí odkaz:
https://doaj.org/article/f1e3a9ad7e9f488eb530620e573a618a
Autor:
N V Bakulina, Igor V. Maev, Ekaterina V. Skazyvaeva, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev, Aleksei I. Ermakov, Larisa B. Gaikovaya, Mariia S. Zhuravleva, Maria I. Skalinskaya, Igor G. Bakulin
Publikováno v:
Терапевтический архив, Vol 93, Iss 8, Pp 841-852 (2021)
Treatment of inflammatory bowel diseases IBD (Crohns disease, ulcerative colitis) is aimed at achieving clinical, endoscopic and histological remission, minimizing surgical complications, and ensuring a normal quality of life. However, the use of med
Inflammatory bowel diseases during the coronavirus pandemic: potential risks and ways to reduce them
Publikováno v:
HERALD of North-Western State Medical University named after I.I. Mechnikov. 12:5-10
This review is devoted to the current issues on management of the patients with inflammatory bowel diseases during the new coronavirus SARS-CoV-2 pandemic. Since March 2020, the World Health Organization with the support of international gastroentero
Autor:
Igor G. Bakulin, Alexey V. Veselov, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva, Diana A. Komarova, Irina A. Rasmagina, Igor V. Maev, Yurii A. Shelygin
Publikováno v:
Annals of the Russian academy of medical sciences. 75:27-35
Inflammatory bowel diseases (IBD) are immune-mediated diseases and usually manifest at a young age. They are requires in a long-term treatment or surgery with a high probability of surgical intervention. IBDs are accompanied by a decrease in working
Autor:
Igor G. Bakulin, A. A. Topanova, A. B. Avalueva, I. V. Lapinsky, Ekaterina V. Skazyvaeva, Stanislav Sitkin, A. A. Murzina, A. V. Pushkina
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 6, Pp 496-504 (2019)
Rationale: Irritable bowel syndrome (IBS) is a multifactorial disease, the genetic aspect of which is being actively studied.Aim: To investigate functional polymorphism of the serotonin reuptake transporter (SERT) SLC6A4 gene of various clinical vari
Publikováno v:
Терапевтический архив, Vol 93, Iss 8, Pp 963-968 (2021)
Liver cirrhosis (LC) takes the main place in the structure of the pathology of the digestive system in terms of the frequency of mortality, as well as in the development of fatal and poorly controlled complications, which requires the search for effe